$Passage Bio (PASG.US)$ Passage Bio Announced Initial Safety...

Trytosaveabit commented on a stock · Dec 20, 2023 06:33

$Passage Bio(PASG.US)$ Passage Bio Announced Initial Safety And Biomarker Data From Three Cohort 1 Patients In The Ongoing Global Phase 1/2 UpliFT-D Trial Of PBFT02, An Adeno-associated Virus-delivery Gene Therapy For Frontotemporal Dementia With Granulin Mutations

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

1794 Views

Comment

Trytosaveabit

1733Followers

28Following

20KVisitors